Online Event

Global Experts Meeting on

Cells & Advanced Stem Cell Research

Theme: The Novel Stem Cells Research

Event Date & Time

Event Location

Online Event

Program Abstract Registration Awards 2020

18 years of lifescience communication

442382146717

Performers / Professionals From Around The Globe

Tracks & Key Topics

stem cell conferences 2020

About Conference

EuroSciCon invites all the participants from across the globe to attend "Global Experts Meeting on Cells & Advanced Stem Cell Research”, on September 9-10, 2020 in Budapest, Hungary, which includes prompt keynote presentations, poster presentations, oral talks, and exhibitions.

Stem cells are unique cells with an ability to differentiate in any other cells of the body. Two types of stem cells found in the body, embryonic and somatic, hold the enormous therapeutic potential to repair and regenerate damaged tissues. Regenerative medicine is an application of stem cell research which harnesses the potential of tissue engineering to stimulate repair mechanism of body and restore the damaged tissues and organs. Therefore, development of disease-specific therapies and treatments by exploiting the remarkable properties of stem cells holds hope for improvement of the quality of life and survival of patients with chronic disorders.

The theme of this year’s meeting is “The Novel Stem Cells Research”. Stem Cell Conferences 2020 aim is to provide the recent research topics where all the participants would get the opportunity to discuss the latest developments in the field of Stem Cell and Regenerative Medicine as well. Current studies of Stem cell are examining how undifferentiated organisms might be utilized to anticipate or fix sicknesses and wounds, for example, Parkinson's illness, type 1 diabetes, coronary illness, spinal string damage, strong dystrophy, Alzheimer's malady, strokes, osteoarthritis, and vision and hearing misfortune. Immature microorganisms could likewise be utilized to supplant, or repair tissue harmed by ailment or damage.

What is New?

Stem Cell Conference includes international attendee workshops, lectures and symposia, including a designated registration area, a respite and regalement. Stem Cell educators can join the EuroSciCon as an international member to receive discounts on registration. So come and join leading experts and allied professionals from September 9-10, 2020 in Budapest, Hungary to keep up with the rapidly accelerating pace of change that is already having an impact on the field of Stem cell, and will continue to in the future.

Sessions/Tracks

SESSION 1 : STEM CELLS- AN INSIGHT

Stem cells are uniform cells found in cellular organisms that divide through cellular division and differentiate into specialized cells. The two classical properties of stem cells which permit them to differentiate into nearly any quite body cell are self- renewal and efficiency. Thanks to their potential role in various therapies, stem cells is a subject of in-depth analysis of Extensive Research Science.

SESSION 2 : STEM CELLS AND BIO ENGINEERING

Stem Cell culture and Regenerative drugs largely targeted in creation of practical body tissues which might be model, repair and replace the broken part that hold an opening to make whole organ and tissue Regeneration by technology of stem cells in Vitro. So as to get desired organ and tissue for transplantation, rather than that genetic and molecular sweetening of somatic cell could be a powerful mean to correct hereditary condition in patient these novel approach will eradicate the limitation of donor for transplantation further as open a replacement path in health science and medicine.

SESSION 3 : MOLECULAR BASIS OF REGENERATION

Regeneration is a universal phenomenon in nature by which lost cells, tissues or body parts are replaced or restored in an organism as a general process of growth.  During this process, adult stem cells or progenitor cells proliferate and differentiate to compensate the loss. The ability to regenerate depends upon the potency of any cell, categorized under totipotent, pluripotent, multipotent, omnipotent and uni-potent.

SESSION 4 : CANCER STEM CELLS

Certain immortal cells among the tumor are capable of proliferating into all different sorts of cancer cells. These cells called cancer stem cells, the first targets of cancer life scientist and medical specialist for treatment of assorted tumors, although they are fairly immune to therapy and therapy. Approaches are created to use the property of those cells to develop immortal cell lines for the assembly of medicine and cytokines relevant to medical use but, heaps additional understanding is needed before transferal the ends up in observe.

SESSION 5 : MODERN TECHNIQUES OF TISSUE ENGINEERING

Tissue Engineering could be a multi-disciplinary science involving the principles of cell biology, Engineering and material sciences to exchange or restore biological tissues that perform a selected perform with a stronger framework. It is an associate act of mixing the cells of construct, scaffold and growth factors into a useful tissue. The feasibleness of bone-marrow derived Mesenchymal stem cells, Viscus valves, Auricular animal tissue reconstruction, etc. explains the large potential of this comparatively new field in medical specialty sciences.

SESSION 6 : ADVANCES IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE

Not all tissues within the body are devised to regenerate when harm. Tissue Regeneration emphasizes on the science of create purposeful body elements for medical treatments aimed toward restoring traditional body functions when sickness, trauma and innate problems. It offers rise to a change of location field of Regenerative drugs, came into existence 20 years past, and harnesses the principles of biological science and tissue engineering. Use of stem cells is Associate in Nursing integral a part of Regenerative drugs that emphasizes the likelihood of culturing tissues and organs in-vitro and their implantation into the topic.

SESSION 7 : REPROGRAMMING IN STEM CELL AND TRANSPLANTATION

Transplantation is that the novel approach of transferring cells, Tissues, in addition as organs kind Donor to recipient to revive the perform of the required organ, tissue and cells. There are a many procedure area unit there autologous (self), allogeneic (person to person), organ transplant (species to species). There are unit many transplantations area unit there that area unit with success approached in humans. Bone marrow transplantation is that the commonest technique used to treat various number of diseases together with Cancer. Rather than that analysis area unit occurring within the method of reprograming the pluripotent vegetative cell to organic process cell will which is ready to be able to treat many diseases in addition as can describe diseases models and induce a replacement hope within the field of Transplantation.

SESSION 8 : TREATMENT OF DISEASES BY STEM CELL THERAPEUTICS

Stem Cell therapy is aimed at treating numerous degenerative, hematopoietic and neuromuscular disorders, nearly 80 in number which cannot be treated with conventional methods. Bone marrow transplantation for blood disorders like, leukemia is the most celebrated application of stem cell therapy, other than skin tissue grafting and implantation. This new approach in medical biology is inclined at maximizing the quality of life by reducing the adversities of chronic disorders such as cancer and genetic diseases.

SESSION 9 : NANO-BIOTECHNOLOGY IN REGENERATIVE MEDICINE

Nano-biotechnology in medical sciences renders some extremely suitable outcomes within which few square measures solely pictured, whereas others square measure at completely different phases of clinical trials or already in follow. Nano-biotechnology in regenerative drugs includes utilization of Nano-particles that square measure being designed these days and pictured analysis that involves usage of Nano-robots to imply changes at cellular and molecular level. Recently, it is being employed for drug-delivery, thermal- and optical maser medical care for cancer treatment. Particles square measure designed in such the way that they are simply being recognized by surface receptors of target cells to make sure direct treatment and least attainable harm to unaffected cells. This technology is additionally exploited for detection of diseases in initial phases for fashioning a good medical care.

SESSION 10 : BIO-INFORMATICS IN STEM CELLRESEARCH

Bioinformatics deals with the event of algorithms and databases to manage, predict and analyze biological information. In-silico analysis of little molecules as a possible drug delivery target may be a preliminary step in drug planning to confirm most effectiveness. Self- learning algorithms, like, artificial neural network, a very important tool for vaccinium planning. Machine biology alongside bioinformatics may be a domain incorporating consolidated facts from applied science engineering, animation, ecology, genomics, immunology, neurobiology, organic chemistry and physics which might be used as pre-knowledge tools for planning somatic cell therapies.

SESSION 11 : STEM CELL BANKING

Umbilical cord blood is highly enriched with pluripotent stem cells which are considered lifesaving in later stages of life as they can treat a host of disorders. Cord blood stem cells are used to target blood disorders, immune deficiencies, and rare metabolic disorders, including leukemia, Krabbe disease, aplastic anemia, non-Hodgkin’s lymphoma and Hodgkin’s lymphoma, sickle-cell anemia and thalassemia, with least chances of rejection by the body. Cord blood preservation of newborn babies, also termed as, stem cell banking, in public or family banks, is gaining a lot of awareness among people as it holds promise for future well-being.

SESSION 12 : GENOMIC EDITING IN STEM CELLS

The development of targeted genome editing technique using custom-engineered sequence-specific nucleases(including CRISPR/Cas9) allowed genetic changes with greater precision. This technique has a widespread application in the reprogramming of stem cells to study disease outcomes. The rapid evolution of these two techniques over years and their relationship with one another has paved a way for understanding cellular interactions and regulation of transcription at a molecular level with appreciable efficiency and flexibility.

SESSION 13 : VIRAL MEDIATED TARGETED GENE THERAPY

Classical strategies of sequence therapy embody transfection. It became inefficient and restricted chiefly to delivery of sequence into actively proliferating cells in-vitro. Sequence Gene therapy utilizes the delivery of polymer into cells by means that of vectors like biological nanoparticles or infective agent vector sand non-viral strategies. The many forms of viruses vectors employed in sequence therapy are animal virus, adeno virus, animal virus and herpes simplex virus. Whereas different recombinant infective agent vector systems are developed, retroviral vectors stay the foremost wide spread vector system for sequence Gene therapy protocols and widest application to their historical significance because the initial vectors developed for economical sequence medical care application and also the infancy of the sector of sequence medical care.

SESSION 14 :  STEM CELLS IN NEUROLOGICAL DISORDERS

Stem cell medical care has emerged as a promising treatment for varied neurological disorders. One such application has been recognized in stroke, a debilitative health burden that affects many thousands of people worldwide. Several patients would greatly take pleasure in the event of novel treatments for stroke with wider therapeutic windows than this restricted treatment, TPA (tissue plasmin activator). Cell medical care for medical specialty disorders suggests that the utilization of cells of neural or non-neural origin to interchange, repair, or enhance the operate of the broken systema nervosum. Varied technologies square measure concerned within the development of cell therapies. These embrace the utilization of stem cells and genetic modification of cells. Many styles of cells are transplanted into the systema nervosum for the treatment of medical specialty disorders.

SESSION 15 : STEM CELLS IN CARDIOVASCULAR DISORDERS

Cardiovascular Diseases (CVD) includes hypertensioncoronary artery disease, stroke and congestive heart failure. Most of these disorders occurred by less oxygen supply to heart cells / Cardiomyocytes which damaged as being supplied by less oxygen as well as less blood which can be treated by stem cell therapy by inducing some bone-marrow derived mononuclear cells, umbilical cord blood cells, Mesenchymal stem cells or Cardiac stem cells in to the damaged portion of heart . These cells integrated in to heart and secrete certain proteins and paracrine factors that repair of the damaged area by cardiac tissue regeneration.

SESSION 16 : TREATMENT OF RARE DISEASES BY GENE THERAPY

Gene therapy may be a logical way to treat rare factor tic disorders and cure one factor defect by introducing with a correct gene. The primary gene-therapy trials were conducted exploitation patients with rare monogenetic disorders, however these area unit currently outstripped by the clinical testing of factor medical specialty for additional common conditions, for ex: cancer, AIDS, and Cardiopathy. This can be part because of a failure to attain semi-permanent organic phenomenon with early vector systems, a  important condition for correcting several inborn genetic defects.

SESSION 17 : STEM CELL CULTURE AND BIOPROCESSING

Getting Cell therapy product onto the market as quickly as doable still remains a key driver within the improvement of recombinant therapeutic proteins. Any such advance in bioprocessing is of specific interest to the business if it significantly shortens the event timeline or improves the top product. Within the antibody (MAb) space, platform procedures have allowed corporations to manage on specific class cell lines, transfection approaches, method conditions and additionally downstream process to shorten the event timeline.

SESSION 18 : BIO ETHICAL ISSUES AND CHALLENGES IN STEM CELL RESEARCH

Stem Cells and their applications in tissue regeneration comes with a few interesting controversies regarding the bioethical issues involved in stem cell research. The collection of somatic stem cells from the human fetuses and umbilical cords is the most extreme controversy so far. Other issues involve the potential of stem cells to induce a tumor in the body and use of embryos which are only few days old. Human embryo cloning was suggested as an alternative to this situation which was highly criticized by the ethical groups. Currently, lack of Stem-Cell marker sand in-vitro systems for manipulation also hinders the research and makes it a daunting task.

SESSION 19 : STEM CELL IN DISEASE MODELLING AND DRUG DISCOVERY

As explained Stem Cells are unspecialized cells that have the potential to completely differentiate in to different kind of cells and tissues that are the building blocks of body, that is finished by the method of regeneration and degeneration which might wont to overcome the restrictions of animal models in sure disorders. in addition as in drug screening and drug discovery. Several ways to generate such unwellness model’s exploitation either Embryonic stem cells (ES cells) or patient-specific induced PSCs (iPSCs), that is making new era within the field of unwellness modelling and drug discovery.

SESSION 20:  CANCER EPIGENETICS

Cancer epigenetics is study of somatically changes to molecular processes that effect the flow of information between the DNA of cancer cells and their gene expression patterns. This includes comparative (tumor cell versus normal cell) investigation of nuclear organization, DNA methylation, histone modification and the consequences of genetic mutations in genes encoding epigenetic regulators. The initiation and advance of cancer, traditionally seen as a genetic disease, is now realized to involve epigenetic abnormalities along with genetic alterations

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!